Organs-on-chips: research and commercial perspectives.Traditional preclinical drug testing methods utilize animal models to predict pharmacology and toxicology profiles.  To overcome these limitations, researchers have developed organs-on-chips - microfluidic devices that can mimic the cellular architecture and physiology more accurately than conventional methods.  We also discuss the current industry and government initiatives in promoting further research on organs-on-chips for potential use during drug development.
Organs-on-chips
To overcome these limitations, researchers have developed organs-on-chips - microfluidic devices that can mimic the cellular architecture and physiology more accurately than conventional methods. 
microfluidic devices
To overcome these limitations, researchers have developed organs-on-chips - microfluidic devices that can mimic the cellular architecture and physiology more accurately than conventional methods. 
conventional methods